Which has the lower trailing P/E, LH or UTHR?

UTHR has the lower trailing P/E: LH trades at 25.77 and UTHR at 17.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, LH or UTHR?

Over the past five years, UTHR grew revenue faster — LH at a -2.62% CAGR versus UTHR at 14.68%.

Does LH or UTHR pay a bigger dividend?

LH pays a dividend (0.94% yield), while UTHR has no payments in the available dividend history.

Is LH or UTHR more profitable?

UTHR runs the higher net margin — LH at 6.99% versus UTHR at 41.56%.

How have LH and UTHR total returns compared?

Over the past 10 years, LH delivered 10.81% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.

Labcorp Holdings Inc. (LH) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Labcorp Holdings Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

Labcorp Holdings Inc.

$25.55B

$311.54HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

UTHR

United Therapeutics Corporation

$21.10B

$497.11HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — LH vs UTHR

growth of $100 · dividends reinvested · last 10y

LH +194.2% (+11.4%/yr)UTHR +312.8% (+15.2%/yr)UTHR compounded faster over this window

LH UTHR

LH vs UTHR: by the numbers

•LH is the larger company ($25.55B vs $21.10B market cap).
•UTHR trades at the lower trailing earnings multiple (17.81 vs 25.77 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (41.56% vs 6.99% net margin).
•UTHR grew revenue faster over the past five years (14.68% vs -2.62% CAGR).
•LH pays a dividend (0.94% yield), while UTHR has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LH	UTHR
P/E ratio	25.77	17.81
Forward P/E	16.98	19.01
P/S ratio	1.78	6.69
P/B ratio	2.97	3.30
EV / EBITDA	13.90	12.91
FCF yield	4.52%	5.18%

Profitability

Metric	LH	UTHR
Gross margin	27.85%	86.14%
Operating margin	11.27%	44.49%
Net margin	6.99%	41.56%
ROE	11.65%	20.48%
ROIC	8.02%	17.69%

Dividends

Metric	LH	UTHR
Dividend yield	0.94%	N/A
Payout ratio	23.82%	N/A

Growth (annualized)

Metric	LH	UTHR
Revenue CAGR (5Y)	-2.62%	14.68%
EPS CAGR (5Y)	-8.00%	20.93%
FCF CAGR (5Y)	-16.45%	14.31%
Total return CAGR (5Y)	4.61%	19.17%

Frequently asked

Which has the lower trailing P/E, LH or UTHR?: UTHR has the lower trailing P/E: LH trades at 25.77 and UTHR at 17.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, LH or UTHR?: Over the past five years, UTHR grew revenue faster — LH at a -2.62% CAGR versus UTHR at 14.68%.
Does LH or UTHR pay a bigger dividend?: LH pays a dividend (0.94% yield), while UTHR has no payments in the available dividend history.
Is LH or UTHR more profitable?: UTHR runs the higher net margin — LH at 6.99% versus UTHR at 41.56%.
How have LH and UTHR total returns compared?: Over the past 10 years, LH delivered 10.81% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LH analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Labcorp P/E ratio United Therapeutics P/E ratio Labcorp dividend yield Labcorp ROE United Therapeutics ROE Labcorp operating margin United Therapeutics operating margin Labcorp revenue growth United Therapeutics revenue growth Labcorp free cash flow United Therapeutics free cash flow

Labcorp & United Therapeutics appear in these rankings

Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.